Metabolic reprogramming from mitochondrial aerobic respiration to aerobic glycolysis is a hallmark of cancer. However, whether it is caused by a dysfunction in the oxidative phosphorylation pathway is still under debate. In this work, we have analyzed the bioenergetic cellular (BEC) index and the relative cell ability to grow in the presence of either galactose or glucose as sources of sugar (Gal/Glu index) of a system formed by four epidermal cell lines with increasing tumorigenic potentials, ranging from nontumorigenic to highly malignant. We find that the BEC index gradually decreases whereas the Gal/Glu index increases with tumorigenicity, indicating that a progressive metabolic adaptation to aerobic glycolysis occurs in tumor cells associated with malignancy. Interestingly, this metabolic adaptation does not appear to be caused by damaged respiration, since the expression and activity of components of the respiratory chain complexes were unchanged in the cell lines. Moreover, the corresponding mitochondrial ATP synthetic abilities of the cell lines were found similar. The production of reactive oxygen species was also measured. A shift in ROS generation was found when compared nontumorigenic with tumorigenic cell lines, the latter exhibiting about threefold higher ROS levels than nontumorigenic cells. This result indicates that oxidative stress is an early event during tumor progression. 
Introduction
In 1927, Otto Warburg put forward the hypothesis that cancer cells undergo a shift in their metabolism from mitochondrial aerobic respiration to glycolysis followed by lactic acid fermentation that would occur even under normoxic conditions. Warburg also proposed that this altered metabolism is caused by defects in the oxidative phosphorylation (OXPHOS) pathway [1] . A bioenergetic signature of cancer cells was proposed by Cuezva and collaborators who showed that the expression of mitochondrial and glycolytic enzymatic markers varies significantly when comparing human carcinomas with paired normal tissues [2] . These authors analyzed a wide variety of tumors, including liver, kidney, colon, breast, lung, gastric and esophageal carcinomas, and concluded that OXPHOS function is reduced during neoplastic transformation. They defined a bioenergetic cellular index, the BEC index, which could be used to estimate the mitochondrial status in human tumors. However, the concept that the respiration of cancer cells is damaged is highly debated, in particular, since the discovery that protooncogenes and tumor suppressor genes besides regulating signal transduction pathways involved in cell cycle control also affect cellular metabolism [3, 4] .
Nowadays, the idea that metabolic reprogramming is a hallmark of cancer is well established, regardless of whether the cause is or is not a defective respiration [3, 5] .
In this work, we have analyzed the OXPHOS status relative to glycolysis in a model of mouse skin carcinogenesis formed by four cell lines with increasing tumorigenic abilities. Mouse skin chemical carcinogenesis is a well-characterized model system to study the genetic and biochemical changes associated with tumor 4 initiation, promotion and progression. In this model, tumors are induced on the skin of mice by treatment with chemicals, either by the "two-stage" or "complete" carcinogenesis protocols [6] . The two-stage protocol involves treatment with a single dose of a carcinogen; i.e., 7, 12-dimethylbenz(a)anthracene (DMBA) followed by repeated applications of the tumor promoter 12-Otetradecanoylphorbol-13-acetate (TPA), which gives rise to the appearance of benign papillomas. A small fraction of papillomas spontaneously progress to malignant squamous cell carcinomas (SCCs), which lately can undergo an epithelial-mesenchymal conversion and form highly aggressive spindle cell carcinomas (SpCC) [7] . Complete carcinogenesis, on the other hand, involves repeated applications of the carcinogen DMBA. Here, DMBA-induced cell lines corresponding to different stages of skin carcinogenesis were used to evaluate whether OXPHOS dysfunctions that lead to increased glycolytic activity occur associated with tumor progression.
Materials and Methods

Cell lines, culture conditions and Gal/Glu index determination
MCA3D cells were derived by treatment of a primary mouse epidermal keratinocyte culture with DMBA, followed by selection in high calcium medium that induces terminal differentiation of normal keratinocytes [8] . PB cells were obtained from a papilloma induced by two-stage carcinogenesis [9] . The A5 cell line was derived from the spindle component of a skin carcinoma induced by complete carcinogenesis [10] , and CarC cells were explanted from a carcinoma induced by two-stage carcinogenesis [11] . A summary of the origin and characteristics of the cell lines is presented in Supplementary Material (Table S1 ).
MCA3D and PB cells have normal H-Ras genes, while both CarC and A5 cell lines exhibit an identical mutation at codon 61 of H-Ras [8, 11, 12] . Moreover, CarC cells show complete loss of the normal H-Ras allele [11] and have the Ink4 locus encoding the cell cycle regulators p15 Ink4b , p16 Ink4b and p19 Arf deleted [13] . A5 cells, on the other hand, have inactivated the tumor suppressor Trp53 gene encoding p53 [10] , whereas CarC has normal Trp53 [14] . Cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM)-Ham's F12 medium (1:1) supplemented with 10% foetal bovine serum, 2mM L-glutamine, and antibiotics: 100 g/ml ampicillin, 60 g/ml gentamicin and 2.5 g/ml amphotericin B. Cells were grown at 37ºC in a 5% CO2-humidified atmosphere.
To compare the cell abilities to grow in the presence of either glucose or galactose as a sugar source, cells were transferred to sugar-free DMEM medium (Gibco) containing glucose (4.5 g/l) or galactose (0.9 g/l) plus the supplements cited above. Cells were incubated up to 8 days, refreshing the medium every 2 days. Doubling times were calculated by applying the suitable formula DT = log 2 x (t -t0) / log N -log N0, where (t -t0) is the total days of incubation and N0 and N, the number of cells at the beginning and end of incubation, respectively. The Gal/Glu index is the ratio of the corresponding doubling times. 
Tumorigenicity assay
Western-blot analysis and BEC index determination
Collected cells were centrifuged and pellets frozen at -20º C until use.
Pellets were lysed in cold RIPA buffer supplemented with complete protease inhibitors cocktail (Roche). The homogenates were kept in ice for at least 15 min and, if necessary, passed through a needle (0.4x13mm) to clarify the extracts before centrifuging at 13,000 rpm and 4ºC for 10 min. The supernatants were saved and the protein content determined with the BCA protein assay kit (Pierce).
Extracts were stored frozen until use.
Protein extracts (20 g) were separated in 10% SDS-PAGE gels and electrotransferred to either Immobilon-P or nitrocellulose membranes (Millipore).
In order to determine the BEC index, membranes were probed with a polyclonal antibody against -ATPase [15] and, subsequently, with monoclonal antibodies recognizing Hsp60 and GAPDH (Stressgen). Appropriate secondary antibodies coupled to horseradish peroxidase were used, and peroxidase activity was developed using either an enhanced chemoluminiscence (ECL) kit (Amersham) or the Odissey detection system (nitrocellulose filters). The signals obtained for each enzyme were quantified by densitometric analysis with Image J program. The BEC 7 index was calculated dividing the ratio -ATPase/Hsp60 by the value obtained for GAPDH [2] .
Determination of protein levels of the respiratory chain subunits was achieved as indicated above using 50 g protein extracts and monoclonal antibodies specific for COXI and NDUFA9 (Mitosciences). A monoclonal antibody against -actin (Sigma) was used as loading control.
Determination of the activity and Blue Native electrophoresis of the respiratory chain complexes
Enzymatic activity measurements were performed with homogenates obtained from 2x10 6 cells grown as described in section 2.1, washed in PBS and resuspended and sonicated in SETH buffer (250 mM sucrose, 2 mM EDTA, 100 U/L Heparine, 10 mM Tris-HCl, pH 7.4). The amount of protein was determined using the DC Protein Assay kit (Bio-Rad). The activities of the respiratory chain complexes I, II, III and IV and the mitochondrial mass marker citrate synthase were measured by spectrophotometric methods as previously described [16] .
Blue native electrophoresis was performed as previously reported [17] .
Mitochondrial protein extracts were obtained by treatment of the cells with 2mg/ml digitonin followed by solubilization of the native complexes with 2% lauryl maltoside. Mitochondrial extracts (40 μg) were loaded on native 4-15% polyacrilamide gradient gels. After electrophoresis, proteins were transferred to a PVDF membrane (Millipore) and probed with the specific complex I monoclonal antibody NDUFA9 (Mitosciences).
In-gel activity assays were performed as described [17] . For complex I activity assay, gels were incubated 1-2 h at 37 ºC in 2 mM Tris-HCl, pH 7.4, 0.1 mg/ml NADH, and 2.5mg/ml nitrotetrazolium blue (NTB). Stained gels were washed with distilled water and scanned.
ATP steady state levels
ATP measurements were carried out as previously described [18] , with some modifications. Briefly, 2x10 5 
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The production of cytoplasmic and mitochondrial ROS was assessed using dichlorodihydrofluorescein diacetate (H2DCFDA, Molecular Probes) and MitoSOX TM red (Invitrogen), respectively.
For DCH2F-DA assays, cells (1x10 6 ) were grown for 48h in ¨glucose/galactose medium¨ (DMEM plus 5% foetal bovine serum, 2 g/l glucose, 2.5 g/l galactose, 100 U/ml penicillin and 100 g/ml streptomycin). Cells were (Fig.   1A, B) . Tumors induced by PB were histologically typed as moderately to welldifferentiated SCCs [9] , whereas those induced by A5 and CarC were highly undifferentiated spindle cell carcinomas [10, 11, 14] .
Mitochondrial function and tumorigenicity: BEC index and OXPHOS activity Cuezva and collaborators defined the BEC index (-F1-ATPase/GADPH
protein ratio) as a bioenergetic mitochondrial index relative to the cellular glycolytic potential [2] . In patients with lung adenocarcinomas, a reduced BEC index correlated with worse prognosis [19] . In order to ascertain whether similar alterations of this bioenergetics signature occurred in our experimental model, we determined BEC index values for MCA3D, PB, A5 and CarC cell lines. As shown in Figure 2A , a clear decrease in the BEC index, ranging from 1.93 in nontumorigenic MCA3D to 0.53 in highly malignant CarC cells, was detected associated with enhanced tumorigenicity. To determine whether this reduction was due to an impaired OXPHOS function, the activity of the respiratory chain complexes was measured in the different cell lines by spectrophotometric assays, as indicated in Materials and methods. No significant differences were found in the activities of the OXPHOS complexes (data not shown). The activity of the complexes was also measured using in-gel activity assays. The activity of complex I together with the levels of fully assembled complex observed in Blue Native gels are shown in Fig.   2B . Also, the expression of proteins markers for complexes I and IV, as determined by Western blotting, is shown in Fig. 2C . No significant differences in these parameters were found between the different cell lines, in accordance with the spectrophotometric analysis.
The gradual decline in the BEC signature associated with enhanced tumorigenicity observed in our cell lines is in line with the proposal of reduced BEC index as a bad prognostic factor in assessing clinical outcome for cancer patients [2, 19] . Apparently, this decrease is not caused by significant changes in the protein composition or activity of the mitochondrial respiratory chain complexes.
Glycolisis and tumorigenicity: Gal/Glu index
Since the activity of the respiratory chain complexes appeared not to be affected in tumorigenic cell lines, the observed reduction in the BEC index could be explained by an increased glycolytic activity or by a defective mitochondrial function not observed in the measurements of the activity of the OXPHOS complexes. To test these possibilities, we measured the relative ability of the different cell lines to grow in galactose versus high glucose medium (Gal/Glu index). Galactose is not utilized efficiently as a glycolytic substrate; therefore only cells with a fully functional OXPHOS system grow in these conditions [20] . Cells with efficient OXPHOS grow equally well in media supplemented with either galactose or glucose.
The doubling times of MCA3D, PB, A5 and CarC cells growing in the presence of either galactose or glucose were measured and the Gal/Glu indexes calculated. We observed an increase in the Gal/Glu index, ranging from 1.12 in MCA3D to 1.67 in CarC, which correlated with the tumorigenic potential of the cell lines (Fig. 3) . Interestingly, cells grew poorly in the presence of galactose, and the observed increase in Gal/Glu index was mainly due to the most efficient growth of tumorigenic cell lines in high glucose medium.
To further investigate the OXPHOS capacity of the cells, we evaluated the ATP contents when the cells grew in 2-deoxyglucose, condition in which ATP is exclusively produced through OXPHOS ( Figure 3B This metabolic change appears not to be caused by impairment of mitochondrial respiration as the capacity to synthesize ATP via OXPHOS and to grow in galactose medium are comparable in all cell lines studied. 
ROS generation and tumorigenicity
Mitochondria are considered the main source of reactive oxygen species (ROS), and ROS production is generally associated with impairments of the respiratory chain [21] . Therefore, in order to ascertain whether alterations in the generation of ROS also occur associated with tumorigenicity, we measured the intracellular ROS levels in the different cell lines. A shift in the generation of ROS was found when comparing nontumorigenic MCA3D cells with tumorigenic PB, A5
and CarC cell lines (Fig. 4) . Tumorigenic cell lines produced similar amounts of ROS that were higher (about threefold) than the amount of ROS generated by MCA3D.
Since papilloma-derived PB is only moderately tumorigenic and spindle carcinoma cell lines A5 and CarC represent advanced stages of skin carcinogenesis [7] , this finding suggests that oxidative stress increases early during tumor progression.
To learn of the intracellular source of ROS, we determined the levels of mitochondrial superoxide anion using MitoSOX, a specific mitochondrial ROS reagent. Interestingly, the results found ( Fig S1) were similar in the different cell lines except in the case of PB that showed a very low level of superoxide, indicating that ROS production in this particular cell line mostly occurs at a site different from the mitochondria, likely the endoplasmic reticulum and/or the plasma membrane.
Likewise, since the levels of mitochondrial superoxide anion of A5 and CarC are similar to that of MCA3D, the increase observed in the total ROS levels produced by the former cell lines with respect to the latter (Fig. 4) seems to be generated outside the mitochondria. 
